Corrigendum to "ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance" [Blood Cells Mol. Dis. 53, (1-2), (June-August 2014) 47-55], doi:10.1016/j.bcmd.2014.02.008

A. F. Ferreira, L. G. Moura, I. Tojal, L. Ambrósio, B. Pinto-Simões, N. Hamerschlak, G. A. Calin, C. Ivan, D. T. Covas, S. Kashima, F. A. Castro

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Corrigendum to "ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance" [Blood Cells Mol. Dis. 53, (1-2), (June-August 2014) 47-55], doi:10.1016/j.bcmd.2014.02.008'. Together they form a unique fingerprint.